Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma

BACKGROUND: This study aimed to evaluate the efficacy and safety of rituximab combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treating patients with diffuse large B-cell lymphoma (DLBCL). METHODS: A total of 144 patients with DLBCL were randomly divided into int...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xin, Zeng, Min, Yang, Shun-e, Liang, Xiao, Ding, Shan-shan, Guo, Li, Li, Shan, Wen, Shu-juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690734/
https://www.ncbi.nlm.nih.gov/pubmed/29137041
http://dx.doi.org/10.1097/MD.0000000000008494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690734/
https://www.ncbi.nlm.nih.gov/pubmed/29137041
http://dx.doi.org/10.1097/MD.0000000000008494

Ejemplares similares